|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's Antibody Therapeutics | ||||||||||||||||
| August 19, 2003 | ||||||||||||||||
|
-, Paradise Point Resort and Spa, San Diego, CA December 1-2, 2003 IBC’s premier conference on Antibody Therapeutics is primarily dedicated to clinical development and business strategies pertaining to antibody therapeutics and is co-located and concurrent with IBC’s 14th Antibody Engineering conference. IBC’s Antibody Therapeutics is where the research community, business experts and clinicians can discuss the issues pertaining to not only the technological development but also the evolving nature of business deals, market forecast, financial trends, and clinical developments of antibody therapeutics. For full details and to register for IBC’s Antibody Therapeutics, go to www.LifeSciencesInfo.com/3020. For full details and to register for IBC’s 14th Antibody Engineering co-located and concurrent conference, go to www.LifeSciencesInfo.com/antibodyeng. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Online: www.LifeSciencesInfo.com/3020 Phone: (508) 616-5550 Fax: (508) 616-5522 E-mail: reg@ibcusa.com | |||||||||||||||
| E-mail: | jprudhomme@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | 208.252.12.2 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||